Added to YB: 2018-12-20
Pitch date: 2018-12-20
AIMT:US [bullish]
Aimmune Therapeutics, Inc.
+37.79%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
Aimmune Therapeutics, Inc., a biopharmaceutical company, develops and commercializes product candidates for the treatment of peanut and other food allergies.
Market Cap
$2.3B
Pitch Price
$25.03
Price Target
N/A
Dividend
N/A
EV/EBITDA
N/A
P/E
-7.68
EV/Sales
N/A
Sector
Biotechnology
Category
N/A
Show full summary:
AIMMUNE THERAPEUTICS INC COM AIMT:US
A summary for this pitch has not been created yet.
Read full article (0 min)